Global Bacterial Pneumonia Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2024

  • receipt Report ID : 158837
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Pharmaceuticals and Healthcare

Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. 

Scope of the Report:

This report studies the Bacterial Pneumonia Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bacterial Pneumonia Therapeutics market by product type and applications/end industries.

Increase in bacterial resistance of streptococcus bacteria, HIV associated pneumonia, rise in prevalence of pneumonia and government initiatives are major factors driving the growth of bacterial pneumonia therapeutics market over the forecast period. According to national statistics UK, in 2013, 5% of deaths in England and Wales are associated due to pneumonia and influenza. Lack of new drugs and improper diagnosis of pneumonia conditions are hindering the growth of this market over the forecast period.

The global Bacterial Pneumonia Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bacterial Pneumonia Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

AstraZeneca

Nabriva Therapeutics

SetLance

Merck

Daiichi Sankyo Company

GlaxoSmithKline

Pfizer

Sanofi Pasteur

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Antibiotics

Vaccines

Market Segment by Applications, can be divided into

Hospital Pharmacies

Retail Pharmacies

Mail Order Pharmacies

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Bacterial Pneumonia Therapeutics Market Overview

1.1 Product Overview and Scope of Bacterial Pneumonia Therapeutics

1.2 Classification of Bacterial Pneumonia Therapeutics by Types

1.2.1 Global Bacterial Pneumonia Therapeutics Revenue Comparison by Types (2017-2023)

1.2.2 Global Bacterial Pneumonia Therapeutics Revenue Market Share by Types in 2017

1.2.3 Antibiotics

1.2.4 Vaccines

1.3 Global Bacterial Pneumonia Therapeutics Market by Application

1.3.1 Global Bacterial Pneumonia Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Mail Order Pharmacies

1.4 Global Bacterial Pneumonia Therapeutics Market by Regions

1.4.1 Global Bacterial Pneumonia Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Bacterial Pneumonia Therapeutics Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Bacterial Pneumonia Therapeutics Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bacterial Pneumonia Therapeutics Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Bacterial Pneumonia Therapeutics Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bacterial Pneumonia Therapeutics Status and Prospect (2013-2023)

1.5 Global Market Size of Bacterial Pneumonia Therapeutics (2013-2023)

2 Manufacturers Profiles

2.1 AstraZeneca

2.1.1 Business Overview

2.1.2 Bacterial Pneumonia Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AstraZeneca Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.2 Nabriva Therapeutics

2.2.1 Business Overview

2.2.2 Bacterial Pneumonia Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Nabriva Therapeutics Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.3 SetLance

2.3.1 Business Overview

2.3.2 Bacterial Pneumonia Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 SetLance Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.4 Merck

2.4.1 Business Overview

2.4.2 Bacterial Pneumonia Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Merck Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.5 Daiichi Sankyo Company

2.5.1 Business Overview

2.5.2 Bacterial Pneumonia Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Daiichi Sankyo Company Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.6 GlaxoSmithKline

2.6.1 Business Overview

2.6.2 Bacterial Pneumonia Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GlaxoSmithKline Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Bacterial Pneumonia Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

2.8 Sanofi Pasteur

2.8.1 Business Overview

2.8.2 Bacterial Pneumonia Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Sanofi Pasteur Bacterial Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 Global Bacterial Pneumonia Therapeutics Market Competition, by Players

3.1 Global Bacterial Pneumonia Therapeutics Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Bacterial Pneumonia Therapeutics Players Market Share

3.2.2 Top 10 Bacterial Pneumonia Therapeutics Players Market Share

3.3 Market Competition Trend

4 Global Bacterial Pneumonia Therapeutics Market Size by Regions

4.1 Global Bacterial Pneumonia Therapeutics Revenue and Market Share by Regions

4.2 North America Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

4.3 Europe Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

4.5 South America Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

5 North America Bacterial Pneumonia Therapeutics Revenue by Countries

5.1 North America Bacterial Pneumonia Therapeutics Revenue by Countries (2013-2018)

5.2 USA Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

5.3 Canada Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

5.4 Mexico Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

6 Europe Bacterial Pneumonia Therapeutics Revenue by Countries

6.1 Europe Bacterial Pneumonia Therapeutics Revenue by Countries (2013-2018)

6.2 Germany Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

6.3 UK Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

6.4 France Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

6.5 Russia Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

6.6 Italy Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Bacterial Pneumonia Therapeutics Revenue by Countries

7.1 Asia-Pacific Bacterial Pneumonia Therapeutics Revenue by Countries (2013-2018)

7.2 China Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

7.3 Japan Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

7.4 Korea Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

7.5 India Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

8 South America Bacterial Pneumonia Therapeutics Revenue by Countries

8.1 South America Bacterial Pneumonia Therapeutics Revenue by Countries (2013-2018)

8.2 Brazil Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

8.3 Argentina Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

8.4 Colombia Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Bacterial Pneumonia Therapeutics by Countries

9.1 Middle East and Africa Bacterial Pneumonia Therapeutics Revenue by Countries (2013-2018)

9.2 Saudi Arabia Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

9.3 UAE Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

9.4 Egypt Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

9.5 Nigeria Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

9.6 South Africa Bacterial Pneumonia Therapeutics Revenue and Growth Rate (2013-2018)

10 Global Bacterial Pneumonia Therapeutics Market Segment by Type

10.1 Global Bacterial Pneumonia Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Global Bacterial Pneumonia Therapeutics Market Forecast by Type (2018-2023)

10.3 Antibiotics Revenue Growth Rate (2013-2023)

10.4 Vaccines Revenue Growth Rate (2013-2023)

11 Global Bacterial Pneumonia Therapeutics Market Segment by Application

11.1 Global Bacterial Pneumonia Therapeutics Revenue Market Share by Application (2013-2018)

11.2 Bacterial Pneumonia Therapeutics Market Forecast by Application (2018-2023)

11.3 Hospital Pharmacies Revenue Growth (2013-2018)

11.4 Retail Pharmacies Revenue Growth (2013-2018)

11.5 Mail Order Pharmacies Revenue Growth (2013-2018)

12 Global Bacterial Pneumonia Therapeutics Market Size Forecast (2018-2023)

12.1 Global Bacterial Pneumonia Therapeutics Market Size Forecast (2018-2023)

12.2 Global Bacterial Pneumonia Therapeutics Market Forecast by Regions (2018-2023)

12.3 North America Bacterial Pneumonia Therapeutics Revenue Market Forecast (2018-2023)

12.4 Europe Bacterial Pneumonia Therapeutics Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Bacterial Pneumonia Therapeutics Revenue Market Forecast (2018-2023)

12.6 South America Bacterial Pneumonia Therapeutics Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Bacterial Pneumonia Therapeutics Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Bacterial Pneumonia Therapeutics Picture

Table Product Specifications of Bacterial Pneumonia Therapeutics

Table Global Bacterial Pneumonia Therapeutics and Revenue (

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery